In a new Perspective, Benjamin Hyams, BA, Karla Kerlikowske, MD, and Rita F. Redberg, MD (
@RFRedberg), write that AI mammography aids are being sold as additions to mammography screening, with direct-to-consumer marketing touting improved cancer-detection rates, despite a lack of evidence of clinical effectiveness. Read the full Perspective:
nej.md/46yYOMP